$DELX (DELEX Pharma) is set to become a dominant force in the global healthcare market, driving innovation & expanding its influence across key sectors.
News: DELEX (DELX) Announces Strong First Quarter 2026 Results with 150% Growth in Pre-Tax Income
Delex Pharma International, Inc. (DPPI), today announced its financial results for the first quarter ended March 31, 2026, reflecting continued growth.
https://t.co/9uWe6scKoL
Delex Healthcare Group continues to soar, seeing the expansion of its operations throughout Southeast Asia. Significant shareholder updates to be released shortly. $DELX
Bounce Mobile Systems is now Delex Healthcare Group, Inc. - $DELX on the OTC Markets in the USA.
BNCM Announces Corporate Name Change to Delex Healthcare and New Ticker Symbol “DELX”
https://t.co/kS87c551t0
Stay tuned for significant material updates regarding our expansion.
BNCM: DELEX CORPORATE ACTIONS & EXPANSION PLANS FOR 2026 $BNCM
"BNCM has submitted applications for its corporate name-change to Delex Healthcare Group and ticker symbol change to DELEX..."
We hope to uplist to OTCQB very shortly.
https://t.co/zYkB6JNEiI
Delex Pharma remains steadfast in its mission to support the medical community through meaningful education, innovation, and partnerships—driving forward a shared vision of improved critical care delivery and patient-centered outcomes in the Philippines.
$BNCM
Airway management remains a challenge in many Philippine healthcare institutions, especially during laryngoscopy and bronchoscopy procedures due to limited imaging tools and complex cases. Delex Pharma responds with the GlideScope® Core™ 15" FHD Monitor Kit. $BNCM
Addressing the growing healthcare needs brought about by the rising prevalence of chronic diseases, including sleep apnea, Delex markets Continuous Positive Airway Pressure (CPAP) devices under the Yuwell brand. $BNCM
Investors can expect that all future financial reports will be audited by PricewaterhouseCoopers.
Furthermore, the company intends to uplist to OTCQB in the near future, with plans to reach Nasdaq.
We've many more exciting updates for investors, and we appreciate your patience.
Audited financials for the year ending on December 31st, 2024 have been posted to OTC Markets for Delex Pharma International: https://t.co/DSjPLF0DRl
Many more updates to come shortly. We thank all investors for their patience. $BNCM
Your safety is non-negotiable— have QUALITY SLEEP and drive safely.
Get the QUALITY SLEEP you deserve with the help of #PalabangProteksyon! Multivitamins + Selenium (EC-Vit) is available at:
https://t.co/pi7zhWfciW
$BNCM
This milestone reinforces the company’s continued commitment to providing safe, effective, and high-quality anesthesia products across the hospitals in the Philippines.
$BNCM
BNCM, Soon-to-be Delex Healthcare Group, Confirms Aggressive Global Growth Strategy After Merger
BNCM, which is transitioning to become Delex Healthcare Group Inc., today provided investors with a strategic update on its operational growth.
https://t.co/iSQp8WmUDU
Abnormal semen liquefaction, where semen doesn't liquefy within 20–30 minutes, can affect fertility in some Filipino couples. Selenium, according to recent studies, may help improve sperm motility. READ MORE: https://t.co/W5W8OlDcr4
$BNCM
SternMed GmbH Syringe Pump SPN 58, a stable, high-quality single-channel syringe pump designed for ease of use, featuring a clear interface and reliable performance for precise medication delivery.
For product inquiries, sign up here: https://t.co/PNB3ucX6iZ
$BNCM
Experience the power of the STERNMED Infusion Pump (IPN 56) in delivering nutrients and medications in controlled amounts for optimal care.
📷 For product inquiries, sign up here: https://t.co/PNB3ucXE8x
$BNCM
Evidence continues to support the power of video laryngoscopy in both emergency and anesthesia settings. Check the details below!
Should you wish to schedule a demo, sign up through this link: https://t.co/PNB3ucX6iZ
$BNCM